§ BIOTECHNOLOGY
USD · Biotechnology

NRIX

NURIX THERAPEUTICS INC
USDSector · BiotechnologyBeta · 1.79
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
117 increased/new, 67 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B3.18EPS (TTM)-3.45
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
BlackRock, Inc.8.9M0.0%+1%
Redmile Group, LLC7.7M7.9%−4%
Vestal Point Capital, LP6.5M2.8%+39%
Deep Track Capital, LP6.3M1.6%−10%
Fidelity Management5.5M0.0%+31%
State Street5.1M0.0%+44%
◇ AC INTELLIGENCE

Top institutional owners for NRIX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER95.2% · 0 holders
OTHER3.0% · 129 holders
DEALER / BANK0.7% · 20 holders
QUALITY / COMPOUNDER0.5% · 18 holders
PASSIVE / INDEX0.5% · 8 holders
TACTICAL / MACRO0.1% · 2 holders
INCOME / DEFENSIVE0.0% · 12 holders
SYSTEMATIC / QUANT0.0% · 5 holders
ACTIVIST0.0% · 1 holder
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for NRIX in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention NRIX yet.